CAM
Cormorant Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Sell |
1,000,000
-350,000
| -26% | -$4.91M | 1.04% | 22 |
|
|
2025
Q1 | $21.1M | Sell |
1,350,000
-475,000
| -26% | -$7.43M | 1.59% | 18 |
|
|
2024
Q4 | $25.4M | Sell |
1,825,000
-500,000
| -22% | -$6.97M | 1.4% | 22 |
|
|
2024
Q3 | $21.6M | Sell |
2,325,000
-200,000
| -8% | -$1.86M | 1.15% | 27 |
|
|
2024
Q2 | $23.5M | Buy |
2,525,000
+400,000
| +19% | +$3.72M | 1.36% | 24 |
|
|
2024
Q1 | $21.1M | Buy |
+2,125,000
| New | +$21.1M | 0.92% | 32 |
|
|
2023
Q3 | – | Sell |
-800,000
| Closed | -$7.62M | – | 51 |
|
|
2023
Q2 | $7.62M | Buy |
+800,000
| New | +$7.62M | 0.43% | 42 |
|
|
2023
Q1 | – | Sell |
-650,000
| Closed | -$9.62M | – | 76 |
|
|
2022
Q4 | $9.62M | Sell |
650,000
-350,000
| -35% | -$5.18M | 0.64% | 40 |
|
|
2022
Q3 | $19.1M | Buy |
+1,000,000
| New | +$19.1M | 1.34% | 28 |
|